Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 7:(100):e52450.
doi: 10.3791/52450.

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart

A C H Pape  1 , Maarten H Bakker  1 , Cheyenne C S Tseng  2 , Maartje M C Bastings  1 , Stefan Koudstaal  2 , Pierfrancesco Agostoni  2 , Steven A J Chamuleau  2 , Patricia Y W Dankers  3
Affiliations

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart

A C H Pape et al. J Vis Exp. .

Abstract

Regeneration of lost myocardium is an important goal for future therapies because of the increasing occurrence of chronic ischemic heart failure and the limited access to donor hearts. An example of a treatment to recover the function of the heart consists of the local delivery of drugs and bioactives from a hydrogel. In this paper a method is introduced to formulate and inject a drug-loaded hydrogel non-invasively and side-specific into the pig heart using a long, flexible catheter. The use of 3-D electromechanical mapping and injection via a catheter allows side-specific treatment of the myocardium. To provide a hydrogel compatible with this catheter, a supramolecular hydrogel is used because of the convenient switching from a gel to a solution state using environmental triggers. At basic pH this ureido-pyrimidinone modified poly(ethylene glycol) acts as a Newtonian fluid which can be easily injected, but at physiological pH the solution rapidly switches into a gel. These mild switching conditions allow for the incorporation of bioactive drugs and bioactive species, such as growth factors and exosomes as we present here in both in vitro and in vivo experiments. The in vitro experiments give an on forehand indication of the gel stability and drug release, which allows for tuning of the gel and release properties before the subsequent application in vivo. This combination allows for the optimal tuning of the gel to the used bioactive compounds and species, and the injection system.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Levy D, et al. Long-Term Trends in the Incidence of and Survival with Heart Failure. The New England Journal of Medicine. 2002;347(18):1397–1402. - PubMed
    1. Roger VL, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;120(1):2–220. - PMC - PubMed
    1. Peppas NA, Huang Y, Torres-Lugo M, Ward JH, Zhang J. Physicochemical foundations and structural design of hydrogels in medicine and biology. Annual Review of Biomedical Engineering. 2000;2(1):9–29. - PubMed
    1. Olsen BD, Kornfield JA, Tirrell DA. Yielding Behavior in Injectable Hydrogels from Telechelic Proteins. Macromolecules. 2010;43(21):9094–9099. - PMC - PubMed
    1. Guvendiren M, Lu HD, Burdick JA. Shear-thinning hydrogels for biomedical applications. Soft Matter. 2012;8(2):260.

Publication types